TITLE

Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of life

AUTHOR(S)
Desmond, Alicia Catherine; Moodley, Dhayendre; Conolly, Catherine A.; Castel, Sandra A.; Coovadia, Hoosen M.
PUB. DATE
April 2015
SOURCE
BMC Pediatrics;2015, Vol. 15 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Adherence to an antiretroviral regimen is imperative for treatment success in both HIV infected adults and children. Likewise, adherence to antiretroviral prophylaxis is critical in HIV prevention. Studies on pediatric adherence are limited, particularly the prophylactic use of antiretroviral drugs and treatment adherence in very young infants. The HIV Prevention Trials Network (HPTN) 046 study (Clinical Trial Registration NCT00074412) determined the safety and efficacy of an extended regimen of nevirapine suspension in infants born to HIV-1 infected women for the prevention of vertical HIV transmission during breastfeeding. As per protocol, adherence to nevirapine prophylaxis was measured by maternal verbal reports. In addition, the pharmacy assessed the unused returned suspension. The aim of this sub-study was to determine the reliability of maternal verbal reports in measuring adherence to antiretroviral prophylaxis in infants in the first 6 weeks of life and evaluating the unused returned nevirapine as an alternative method of measuring adherence. Methods: Maternal verbal reports and pharmacy returns indicative of "missed < 2 doses" were evaluated against a plasma nevirapine concentration of >100 ng/ml in a subgroup of infants at 2, 5 and 6 weeks of age. Plasma nevirapine concentration of >100 ng/ml was used as a marker of adherence (10 times the in vitro IC50 against HIV). Results: Adherence was 87.7% (maternal verbal report) and 71.3% (unused returned medication), as compared to 85.6% by plasma nevirapine concentration. Evaluated against plasma nevirapine concentration <100 ng/ml, the sensitivity and specificity of maternal verbal reports to detect a missed dose in the last 3 days were 75% and 78% (p = 0.03) respectively. Overall, among infants who were classified as adherent based on missed doses by maternal verbal reports and unused returned medication, 88.4% and 87.4% of infants attained a nevirapine concentration above 100 ng/ml respectively. Conclusion: Maternal verbal reports are a reliable measure of adherence to infant antiretroviral prophylaxis in the first 6 weeks of life and could be useful in assessing adherence to antiretroviral treatment in infants younger than 6 weeks. In the absence of resources or expertise to determine plasma drug concentration, we would recommend random assessments of unused returned medication.
ACCESSION #
102605835

 

Related Articles

  • Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis. Permar, Sallie R; Salazar, Maria G; Feng Gao; Fangping Cai; Learn, Gerald H; Kalilani, Linda; Hahn, Beatrice H; Shaw, George M; Salazar-Gonzalez, Jesus F // Retrovirology;2013, Vol. 10 Issue 1, p1 

    Background: Intrapartum administration of single-dose nevirapine (sdNVP) reduces perinatal HIV-1 transmission in resource-limiting settings by half. Yet this strategy has limited effect on subsequent breast milk transmission, making the case for new treatment approaches to extend maternal/infant...

  • Postnatal antiretroviral prophylaxis may reduce risk for HIV transmission. Levitan, Dave // Infectious Diseases in Children;Apr2008, Vol. 21 Issue 4, p59 

    The article focuses on the results of a study on the use of extended infant post-exposure prophylaxis with antiretroviral drugs to reduce postnatal HIV transmission, which was presented at the 15th Conference on Retroviruses and Opportunistic Infections held in Boston, Massachusetts. The study...

  • Global: clinical trial shows dramatic reduction in transmission of HIV as a result of treatment. Cozac, David // HIV/AIDS Policy & Law Review;Oct2011, Vol. 15 Issue 3, p31 

    The article reports on a clinical trial conducted by the U.S. HIV Prevention Trials Network which revealed that human immunopdeficiency virus (HIV)-positive persons' adherence to an effective antiretroviral therapy reduce the risk of virus transmission by 96 percent. The trial confirmed that HIV...

  • The Strategic Use of Antiretrovirals to Prevent HIV Infection: A Converging Agenda. Baggaley, Rachel; Doherty, Meg; Ball, Andrew; Ford, Nathan; Hirnschall, Gottfried // Clinical Infectious Diseases;2015 Supplement, Vol. 60, pS159 

    There is a clear convergence toward an overarching strategic use of antiretroviral drugs to prevent human immunodeficiency virus (HIV) infection. Four interventions-immediate antiretroviral therapy (ART) for the infected partner in a serodiscordant couple, preexposure prophylaxis (PrEP),...

  • HPTN 071 (PopART): A Cluster-Randomized Trial of the Population Impact of an HIV Combination Prevention Intervention Including Universal Testing and Treatment: Mathematical Model. Cori, Anne; Ayles, Helen; Beyers, Nulda; Schaap, Ab; Floyd, Sian; Sabapathy, Kalpana; Eaton, Jeffrey W.; Hauck, Katharina; Smith, Peter; Griffith, Sam; Moore, Ayana; Donnell, Deborah; Vermund, Sten H.; Fidler, Sarah; Hayes, Richard; Fraser, Christophe // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Background: The HPTN 052 trial confirmed that antiretroviral therapy (ART) can nearly eliminate HIV transmission from successfully treated HIV-infected individuals within couples. Here, we present the mathematical modeling used to inform the design and monitoring of a new trial aiming to test...

  • Myron Cohen ponders path to HIV prevention.  // Journal of Clinical Investigation;May2009, Vol. 119 Issue 5, p1054 

    The article presents an interview with Myron Cohen, a researcher at the University of North Carolina at Chapel Hill. He states that better biological tools and a vaccine are needed to stem HIV transmission. Cohen discusses his antiretroviral treatment (ART) clinical trials. He notes challenges...

  • START TRIAL FINDS THAT EARLY TREATMENT IMPROVES OUTCOMES FOR PEOPLE WITH HIV. Cairns, Gus // HIV Australia;Jul2015, Vol. 13 Issue 2, p54 

    The article presents a discussion on the importance of immediate treatment for people with HIV infection, adapted from the website aidsmap.com. Topics discussed include the significance of randomised clinical trial for HIV infected people to prevent AIDS development, the effectiveness of...

  • Postnatal antiretroviral prophylaxis may reduce risk for HIV transmission. Levitan, Dave // Infectious Disease News;Mar2008, Vol. 21 Issue 3, p32 

    The article deals with a study about the use of postnatal antiretroviral prophylaxis to reduce the risk for HIV transmission. The researchers found that daily antiretroviral prophylaxis with nevirapine or nevirapine plus zidovudine for the first 14 weeks after birth significantly lessened the...

  • Higher Placental Anti-Inflammatory IL-10 Cytokine Expression in HIV-1 Infected Women Receiving Longer Zidovudine Prophylaxis Associated with Nevirapine. Pornprasert, Sakorn; Mary, Jean-Yves; Faye, Albert; Leechanachai, Pranee; Limtrakul, Aram; Rugpao, Sungwal; Sirivatanapa, Pannee; Gomuthbutra, Vorapin; Matanasaravoot, Wanmanee; Le Coeur, Sophie; Lallemant, Marc; Barré-Sinoussi, Françoise; Menu, Elisabeth; Ngo-Giang-Huong, Nicole // Current HIV Research;Mar2009, Vol. 7 Issue 2, p211 

    Placental cytokine balance may be critical for the control of mother-to-child transmission (MTCT) of HIV. We assessed whether the type and duration of antiretrovirals used for prevention of HIV-1-MTCT modified the inflammatory cytokine profile. We investigated the levels of cytokine expression...

Share

Other Topics